泰格医药-公司更新演示的十大要点

January 20, 2026 12:55 PM GMT Hangzhou Tigermed Consulting | Asia Pacific M Update Ten Takeaways from Updated Company Presentation Tigermed's updated presentation at a broker conference last week in the US shed light on China's clinical CRO industry. Key Takeaways 1. About 50% of clinical trials conducted in China were outsourced to CROs from 2019-2025. 2. Market CAGR slowed from Covid's 25% (2020-2022) to post-Covid's 4% (2023- 2024), but is projected to accelerate to 13% (2025-2028, Frost & Sullivan, Huma ...